Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.72206429 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.72206429 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.41609429 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.41609429 |
5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.96116063 |
6 | aromatic amino acid family catabolic process (GO:0009074) | 5.93868775 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.75015789 |
8 | bile acid biosynthetic process (GO:0006699) | 5.35885037 |
9 | urea metabolic process (GO:0019627) | 5.30478454 |
10 | urea cycle (GO:0000050) | 5.30478454 |
11 | kynurenine metabolic process (GO:0070189) | 5.26538419 |
12 | indolalkylamine catabolic process (GO:0046218) | 5.25358878 |
13 | tryptophan catabolic process (GO:0006569) | 5.25358878 |
14 | indole-containing compound catabolic process (GO:0042436) | 5.25358878 |
15 | complement activation, alternative pathway (GO:0006957) | 5.22042115 |
16 | sulfur amino acid catabolic process (GO:0000098) | 5.11509029 |
17 | glyoxylate metabolic process (GO:0046487) | 5.11388768 |
18 | cysteine metabolic process (GO:0006534) | 5.08368933 |
19 | negative regulation of fibrinolysis (GO:0051918) | 5.02795679 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02448343 |
21 | regulation of protein activation cascade (GO:2000257) | 5.01656905 |
22 | tryptophan metabolic process (GO:0006568) | 4.97318303 |
23 | protein carboxylation (GO:0018214) | 4.88425780 |
24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88425780 |
25 | regulation of apoptotic cell clearance (GO:2000425) | 4.86327395 |
26 | nitrogen cycle metabolic process (GO:0071941) | 4.84505983 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.84003129 |
28 | regulation of fibrinolysis (GO:0051917) | 4.76045714 |
29 | regulation of complement activation (GO:0030449) | 4.71607844 |
30 | regulation of triglyceride catabolic process (GO:0010896) | 4.71312019 |
31 | homocysteine metabolic process (GO:0050667) | 4.69753113 |
32 | bile acid metabolic process (GO:0008206) | 4.62574832 |
33 | serine family amino acid catabolic process (GO:0009071) | 4.58743768 |
34 | blood coagulation, intrinsic pathway (GO:0007597) | 4.58694735 |
35 | lysine catabolic process (GO:0006554) | 4.55911006 |
36 | lysine metabolic process (GO:0006553) | 4.55911006 |
37 | plasma lipoprotein particle clearance (GO:0034381) | 4.52993445 |
38 | plasma lipoprotein particle organization (GO:0071827) | 4.47412052 |
39 | triglyceride homeostasis (GO:0070328) | 4.45643740 |
40 | acylglycerol homeostasis (GO:0055090) | 4.45643740 |
41 | amino-acid betaine metabolic process (GO:0006577) | 4.43309162 |
42 | tyrosine metabolic process (GO:0006570) | 4.43167284 |
43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.40943251 |
44 | reverse cholesterol transport (GO:0043691) | 4.31367075 |
45 | protein-lipid complex subunit organization (GO:0071825) | 4.30500218 |
46 | aromatic amino acid family metabolic process (GO:0009072) | 4.29850593 |
47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.28062369 |
48 | protein-lipid complex remodeling (GO:0034368) | 4.28062369 |
49 | macromolecular complex remodeling (GO:0034367) | 4.28062369 |
50 | alpha-amino acid catabolic process (GO:1901606) | 4.20672338 |
51 | positive regulation of extracellular matrix organization (GO:1903055) | 4.20017788 |
52 | regulation of cholesterol esterification (GO:0010872) | 4.19427648 |
53 | phospholipid efflux (GO:0033700) | 4.12684648 |
54 | valine metabolic process (GO:0006573) | 4.10021271 |
55 | intestinal cholesterol absorption (GO:0030299) | 4.06945761 |
56 | positive regulation of lipid catabolic process (GO:0050996) | 4.06565763 |
57 | acetyl-CoA metabolic process (GO:0006084) | 4.05893146 |
58 | negative regulation of sterol transport (GO:0032372) | 4.04220670 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.04220670 |
60 | negative regulation of protein activation cascade (GO:2000258) | 4.03643676 |
61 | ethanol oxidation (GO:0006069) | 4.02741235 |
62 | positive regulation of blood coagulation (GO:0030194) | 4.01794021 |
63 | positive regulation of hemostasis (GO:1900048) | 4.01794021 |
64 | glycine metabolic process (GO:0006544) | 3.93587781 |
65 | phospholipid homeostasis (GO:0055091) | 3.93325349 |
66 | coenzyme catabolic process (GO:0009109) | 3.93193046 |
67 | cellular amino acid catabolic process (GO:0009063) | 3.91834426 |
68 | regulation of humoral immune response (GO:0002920) | 3.90593548 |
69 | bile acid and bile salt transport (GO:0015721) | 3.87773783 |
70 | 2-oxoglutarate metabolic process (GO:0006103) | 3.84368529 |
71 | fatty acid beta-oxidation (GO:0006635) | 3.82807411 |
72 | cellular ketone body metabolic process (GO:0046950) | 3.79170772 |
73 | plasma lipoprotein particle assembly (GO:0034377) | 3.78890282 |
74 | regulation of cholesterol homeostasis (GO:2000188) | 3.78627735 |
75 | cholesterol efflux (GO:0033344) | 3.76108614 |
76 | positive regulation of coagulation (GO:0050820) | 3.74954821 |
77 | serine family amino acid metabolic process (GO:0009069) | 3.74407876 |
78 | fatty acid oxidation (GO:0019395) | 3.74023061 |
79 | cellular modified amino acid catabolic process (GO:0042219) | 3.73693699 |
80 | acute-phase response (GO:0006953) | 3.72808298 |
81 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.72676711 |
82 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.70847642 |
83 | short-chain fatty acid metabolic process (GO:0046459) | 3.69795785 |
84 | glutamate metabolic process (GO:0006536) | 3.66991358 |
85 | lipid oxidation (GO:0034440) | 3.66248246 |
86 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65297588 |
87 | positive regulation of fatty acid oxidation (GO:0046321) | 3.64998338 |
88 | indolalkylamine metabolic process (GO:0006586) | 3.64619364 |
89 | cytolysis (GO:0019835) | 3.63937408 |
90 | fatty acid catabolic process (GO:0009062) | 3.63898430 |
91 | cellular glucuronidation (GO:0052695) | 3.62847012 |
92 | imidazole-containing compound metabolic process (GO:0052803) | 3.62328866 |
93 | low-density lipoprotein particle clearance (GO:0034383) | 3.62280811 |
94 | protein activation cascade (GO:0072376) | 3.62268101 |
95 | regulation of plasminogen activation (GO:0010755) | 3.61894342 |
96 | benzene-containing compound metabolic process (GO:0042537) | 3.61626914 |
97 | negative regulation of lipase activity (GO:0060192) | 3.60833072 |
98 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.59608774 |
99 | monocarboxylic acid catabolic process (GO:0072329) | 3.59493138 |
100 | negative regulation of blood coagulation (GO:0030195) | 3.59452633 |
101 | negative regulation of hemostasis (GO:1900047) | 3.59452633 |
102 | fatty acid transmembrane transport (GO:1902001) | 3.59355603 |
103 | organic acid catabolic process (GO:0016054) | 3.58834383 |
104 | carboxylic acid catabolic process (GO:0046395) | 3.58834383 |
105 | cholesterol homeostasis (GO:0042632) | 3.56598609 |
106 | serine family amino acid biosynthetic process (GO:0009070) | 3.52541431 |
107 | fibrinolysis (GO:0042730) | 3.52178653 |
108 | sterol homeostasis (GO:0055092) | 3.50514524 |
109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.50127837 |
110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.49720821 |
111 | protein-lipid complex assembly (GO:0065005) | 3.49271872 |
112 | amine catabolic process (GO:0009310) | 3.48884282 |
113 | cellular biogenic amine catabolic process (GO:0042402) | 3.48884282 |
114 | complement activation (GO:0006956) | 3.45792286 |
115 | pinocytosis (GO:0006907) | 3.45646399 |
116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45287730 |
117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45287730 |
118 | arginine metabolic process (GO:0006525) | 3.38057645 |
119 | regulation of cholesterol metabolic process (GO:0090181) | 3.37769006 |
120 | lipoprotein metabolic process (GO:0042157) | 3.31717897 |
121 | cholesterol transport (GO:0030301) | 3.28176319 |
122 | sterol transport (GO:0015918) | 3.28176319 |
123 | negative regulation of coagulation (GO:0050819) | 3.27638334 |
124 | negative regulation of complement activation (GO:0045916) | 3.27036609 |
125 | negative regulation of lipid transport (GO:0032369) | 3.26809694 |
126 | ethanol metabolic process (GO:0006067) | 3.23145199 |
127 | positive regulation of steroid metabolic process (GO:0045940) | 3.20330519 |
128 | negative regulation of humoral immune response (GO:0002921) | 3.18512504 |
129 | negative regulation of wound healing (GO:0061045) | 3.16932841 |
130 | complement activation, classical pathway (GO:0006958) | 3.12601956 |
131 | regulation of cholesterol storage (GO:0010885) | 3.10651546 |
132 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.01879916 |
133 | detection of molecule of bacterial origin (GO:0032490) | 2.95920114 |
134 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.90991041 |
135 | regulation of extracellular matrix organization (GO:1903053) | 2.89279650 |
136 | regulation of bile acid biosynthetic process (GO:0070857) | 2.87822585 |
137 | acute inflammatory response (GO:0002526) | 2.81623231 |
138 | positive regulation of phagocytosis (GO:0050766) | 2.80609408 |
139 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.79909629 |
140 | positive regulation of wound healing (GO:0090303) | 2.76725189 |
141 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.74288085 |
142 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.74288085 |
143 | acylglycerol catabolic process (GO:0046464) | 2.73102753 |
144 | neutral lipid catabolic process (GO:0046461) | 2.73102753 |
145 | intestinal absorption (GO:0050892) | 2.71045917 |
146 | oligosaccharide catabolic process (GO:0009313) | 2.69637247 |
147 | diacylglycerol metabolic process (GO:0046339) | 2.68091800 |
148 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.66495972 |
149 | epoxygenase P450 pathway (GO:0019373) | 2.63175887 |
150 | progesterone metabolic process (GO:0042448) | 2.62095004 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.51190859 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.56334741 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.36495751 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.05296835 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.69159491 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.77908099 |
7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.16901909 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01348865 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.16837194 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85808479 |
11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.60817357 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27473690 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.23708209 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11218232 |
15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00099455 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4491969 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94794371 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92061156 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83108113 |
20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.74697358 |
21 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73884327 |
22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72763537 |
23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71691329 |
24 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.70283893 |
25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66377660 |
26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51286982 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.50540603 |
28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49757931 |
29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48608628 |
30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43791847 |
31 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.41911114 |
32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41904743 |
33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38796838 |
34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37838540 |
35 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36822862 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34932333 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.31028481 |
38 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30705402 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30442075 |
40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30122964 |
41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27273734 |
42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26914447 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25652455 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25262659 |
45 | MYC_22102868_ChIP-Seq_BL_Human | 1.22057248 |
46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19738049 |
47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19656217 |
48 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19035979 |
49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17267909 |
50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17241297 |
51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16565240 |
52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16305124 |
53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15226046 |
54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11711788 |
55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10478464 |
56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10119753 |
57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08064253 |
58 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08022217 |
59 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02745047 |
60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02233501 |
61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01423586 |
62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00856508 |
63 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00486517 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00200846 |
65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99922279 |
66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99658543 |
67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99228503 |
68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99106011 |
69 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98970570 |
70 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96980258 |
71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96726677 |
72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96641147 |
73 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.95350150 |
74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95258624 |
75 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95058416 |
76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94569015 |
77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93950523 |
78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93067178 |
79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91813630 |
80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91022088 |
81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90215697 |
82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88694127 |
83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87723706 |
84 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87361892 |
85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87101002 |
86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84721425 |
87 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83694176 |
88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81364171 |
89 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80298136 |
90 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80298136 |
91 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77853070 |
92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77418468 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75787324 |
94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75286764 |
95 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73094657 |
96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71141339 |
97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70929639 |
98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70637246 |
99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70637246 |
100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69731980 |
101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68057316 |
102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67992733 |
103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67896254 |
104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67184883 |
105 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.65623017 |
106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64763826 |
107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64390964 |
108 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.64353066 |
109 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.63483169 |
110 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62672895 |
111 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62335071 |
112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61064791 |
113 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60982463 |
114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60925024 |
115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60912847 |
116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59056810 |
117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.58366429 |
118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.57156257 |
119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.57057365 |
120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56348371 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56311253 |
122 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.55890073 |
123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54921510 |
124 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.53804420 |
125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53511550 |
126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53144918 |
127 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.53103074 |
128 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53047944 |
129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.52199442 |
130 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.52082116 |
131 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.51581970 |
132 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50095941 |
133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49628722 |
134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49348040 |
135 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.47499858 |
136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.47179657 |
137 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.46011006 |
138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.45872472 |
139 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.45213387 |
140 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.44562803 |
141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44541127 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.40575611 |
2 | MP0005360_urolithiasis | 6.60143201 |
3 | MP0005365_abnormal_bile_salt | 6.07162495 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.77382537 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.16767238 |
6 | MP0010329_abnormal_lipoprotein_level | 3.68032544 |
7 | MP0003252_abnormal_bile_duct | 3.62050085 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.49609056 |
9 | MP0005083_abnormal_biliary_tract | 3.19577442 |
10 | MP0009840_abnormal_foam_cell | 2.73233283 |
11 | MP0005058_abnormal_lysosome_morphology | 2.72734473 |
12 | MP0001666_abnormal_nutrient_absorption | 2.71195606 |
13 | MP0003172_abnormal_lysosome_physiology | 2.47018004 |
14 | MP0005332_abnormal_amino_acid | 2.44506503 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.35068499 |
16 | MP0005670_abnormal_white_adipose | 2.28730792 |
17 | MP0000609_abnormal_liver_physiology | 2.27355705 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.25351187 |
19 | MP0003303_peritoneal_inflammation | 2.15771830 |
20 | MP0002132_abnormal_respiratory_system | 1.97545696 |
21 | MP0003705_abnormal_hypodermis_morpholog | 1.93222450 |
22 | MP0003195_calcinosis | 1.90706303 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.80627127 |
24 | MP0004019_abnormal_vitamin_homeostasis | 1.78528815 |
25 | MP0003868_abnormal_feces_composition | 1.77175884 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.76584027 |
27 | MP0004130_abnormal_muscle_cell | 1.69121226 |
28 | MP0001915_intracranial_hemorrhage | 1.65966347 |
29 | MP0004883_abnormal_blood_vessel | 1.54051936 |
30 | MP0003950_abnormal_plasma_membrane | 1.53191270 |
31 | MP0003828_pulmonary_edema | 1.52867470 |
32 | MP0002419_abnormal_innate_immunity | 1.50645117 |
33 | MP0005666_abnormal_adipose_tissue | 1.49292658 |
34 | MP0006054_spinal_hemorrhage | 1.48338162 |
35 | MP0001764_abnormal_homeostasis | 1.44164141 |
36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42518297 |
37 | MP0002971_abnormal_brown_adipose | 1.34815272 |
38 | MP0003011_delayed_dark_adaptation | 1.33219976 |
39 | MP0002254_reproductive_system_inflammat | 1.30852164 |
40 | MP0006082_CNS_inflammation | 1.28768266 |
41 | MP0002998_abnormal_bone_remodeling | 1.28044147 |
42 | MP0001835_abnormal_antigen_presentation | 1.25663959 |
43 | MP0001545_abnormal_hematopoietic_system | 1.23036136 |
44 | MP0005397_hematopoietic_system_phenotyp | 1.23036136 |
45 | MP0009643_abnormal_urine_homeostasis | 1.22804887 |
46 | MP0002837_dystrophic_cardiac_calcinosis | 1.22565241 |
47 | MP0003186_abnormal_redox_activity | 1.21497899 |
48 | MP0000858_altered_metastatic_potential | 1.21258015 |
49 | MP0003122_maternal_imprinting | 1.18509461 |
50 | MP0001533_abnormal_skeleton_physiology | 1.17597337 |
51 | MP0000598_abnormal_liver_morphology | 1.17024757 |
52 | MP0005025_abnormal_response_to | 1.15347097 |
53 | MP0000685_abnormal_immune_system | 1.14412852 |
54 | MP0003566_abnormal_cell_adhesion | 1.14392894 |
55 | MP0009697_abnormal_copulation | 1.14000563 |
56 | MP0005076_abnormal_cell_differentiation | 1.13826966 |
57 | MP0005451_abnormal_body_composition | 1.13220230 |
58 | MP0005334_abnormal_fat_pad | 1.09492420 |
59 | MP0002876_abnormal_thyroid_physiology | 1.07720064 |
60 | MP0001851_eye_inflammation | 1.07718894 |
61 | MP0005647_abnormal_sex_gland | 1.07686407 |
62 | MP0008004_abnormal_stomach_pH | 1.06710529 |
63 | MP0009763_increased_sensitivity_to | 1.04986484 |
64 | MP0004185_abnormal_adipocyte_glucose | 1.04724066 |
65 | MP0009785_altered_susceptibility_to | 1.04537762 |
66 | MP0010368_abnormal_lymphatic_system | 1.01580248 |
67 | MP0005409_darkened_coat_color | 1.01497069 |
68 | MP0009764_decreased_sensitivity_to | 0.97641085 |
69 | MP0002405_respiratory_system_inflammati | 0.97084811 |
70 | MP0002089_abnormal_postnatal_growth/wei | 0.97032350 |
71 | MP0005375_adipose_tissue_phenotype | 0.96814432 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 0.95670655 |
73 | MP0003075_altered_response_to | 0.95267028 |
74 | MP0001661_extended_life_span | 0.93444449 |
75 | MP0002933_joint_inflammation | 0.92840569 |
76 | MP0000604_amyloidosis | 0.91865179 |
77 | MP0002396_abnormal_hematopoietic_system | 0.90251821 |
78 | MP0005220_abnormal_exocrine_pancreas | 0.89746021 |
79 | MP0009115_abnormal_fat_cell | 0.87748413 |
80 | MP0008438_abnormal_cutaneous_collagen | 0.87368428 |
81 | MP0002078_abnormal_glucose_homeostasis | 0.86526164 |
82 | MP0003183_abnormal_peptide_metabolism | 0.86007917 |
83 | MP0008260_abnormal_autophagy | 0.85377144 |
84 | MP0009333_abnormal_splenocyte_physiolog | 0.85319981 |
85 | MP0008469_abnormal_protein_level | 0.85111679 |
86 | MP0003091_abnormal_cell_migration | 0.84769432 |
87 | MP0005408_hypopigmentation | 0.84763565 |
88 | MP0010155_abnormal_intestine_physiology | 0.84664801 |
89 | MP0001790_abnormal_immune_system | 0.82729429 |
90 | MP0005387_immune_system_phenotype | 0.82729429 |
91 | MP0001845_abnormal_inflammatory_respons | 0.81800781 |
92 | MP0005000_abnormal_immune_tolerance | 0.81779029 |
93 | MP0009642_abnormal_blood_homeostasis | 0.79490061 |
94 | MP0005535_abnormal_body_temperature | 0.78658767 |
95 | MP0005448_abnormal_energy_balance | 0.77988676 |
96 | MP0003724_increased_susceptibility_to | 0.76639010 |
97 | MP0001800_abnormal_humoral_immune | 0.76098187 |
98 | MP0002723_abnormal_immune_serum | 0.76020890 |
99 | MP0010234_abnormal_vibrissa_follicle | 0.75297749 |
100 | MP0002148_abnormal_hypersensitivity_rea | 0.74727982 |
101 | MP0003690_abnormal_glial_cell | 0.74353398 |
102 | MP0003300_gastrointestinal_ulcer | 0.74247217 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.74215589 |
104 | MP0004947_skin_inflammation | 0.72685380 |
105 | MP0002452_abnormal_antigen_presenting | 0.72472450 |
106 | MP0002970_abnormal_white_adipose | 0.70531241 |
107 | MP0009278_abnormal_bone_marrow | 0.70378452 |
108 | MP0006036_abnormal_mitochondrial_physio | 0.68139605 |
109 | MP0001881_abnormal_mammary_gland | 0.67289558 |
110 | MP0005636_abnormal_mineral_homeostasis | 0.66821549 |
111 | MP0005376_homeostasis/metabolism_phenot | 0.66672375 |
112 | MP0000465_gastrointestinal_hemorrhage | 0.65919275 |
113 | MP0009384_cardiac_valve_regurgitation | 0.65565274 |
114 | MP0004808_abnormal_hematopoietic_stem | 0.65454241 |
115 | MP0010630_abnormal_cardiac_muscle | 0.63851748 |
116 | MP0001756_abnormal_urination | 0.61777402 |
117 | MP0002060_abnormal_skin_morphology | 0.61463598 |
118 | MP0003959_abnormal_lean_body | 0.59984075 |
119 | MP0005084_abnormal_gallbladder_morpholo | 0.59706413 |
120 | MP0005275_abnormal_skin_tensile | 0.59499145 |
121 | MP0002796_impaired_skin_barrier | 0.59465348 |
122 | MP0002166_altered_tumor_susceptibility | 0.55437918 |
123 | MP0002168_other_aberrant_phenotype | 0.53343761 |
124 | MP0005266_abnormal_metabolism | 0.52803809 |
125 | MP0001853_heart_inflammation | 0.52609361 |
126 | MP0003436_decreased_susceptibility_to | 0.51942809 |
127 | MP0004272_abnormal_basement_membrane | 0.51280428 |
128 | MP0005248_abnormal_Harderian_gland | 0.51066526 |
129 | MP0009053_abnormal_anal_canal | 0.50928777 |
130 | MP0000003_abnormal_adipose_tissue | 0.50754128 |
131 | MP0005023_abnormal_wound_healing | 0.48685480 |
132 | MP0002136_abnormal_kidney_physiology | 0.47925653 |
133 | MP0004381_abnormal_hair_follicle | 0.46810435 |
134 | MP0003453_abnormal_keratinocyte_physiol | 0.46598197 |
135 | MP0005464_abnormal_platelet_physiology | 0.46352305 |
136 | MP0002269_muscular_atrophy | 0.45728004 |
137 | MP0000639_abnormal_adrenal_gland | 0.44798620 |
138 | MP0005330_cardiomyopathy | 0.44748007 |
139 | MP0009672_abnormal_birth_weight | 0.43969781 |
140 | MP0004782_abnormal_surfactant_physiolog | 0.42906295 |
141 | MP0001243_abnormal_dermal_layer | 0.42218122 |
142 | MP0004264_abnormal_extraembryonic_tissu | 0.41750214 |
143 | MP0003329_amyloid_beta_deposits | 0.41331522 |
144 | MP0003953_abnormal_hormone_level | 0.40289672 |
145 | MP0000249_abnormal_blood_vessel | 0.40255827 |
146 | MP0004087_abnormal_muscle_fiber | 0.38830823 |
147 | MP0005164_abnormal_response_to | 0.37746903 |
148 | MP0002928_abnormal_bile_duct | 0.37711951 |
149 | MP0009780_abnormal_chondrocyte_physiolo | 0.37446181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.90152149 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.65711324 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.29771065 |
4 | Xanthomatosis (HP:0000991) | 6.08614934 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.93160974 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 5.67343856 |
7 | Hypobetalipoproteinemia (HP:0003563) | 5.60805047 |
8 | Complement deficiency (HP:0004431) | 5.38187158 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.17314156 |
10 | Epidermoid cyst (HP:0200040) | 4.65074134 |
11 | Hypolipoproteinemia (HP:0010981) | 4.55479131 |
12 | Hyperammonemia (HP:0001987) | 4.48039827 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.36575553 |
14 | Ketosis (HP:0001946) | 4.31436530 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27309411 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.26769878 |
17 | Joint hemorrhage (HP:0005261) | 4.17668684 |
18 | Hyperglycinemia (HP:0002154) | 4.16295381 |
19 | Hyperglycinuria (HP:0003108) | 4.13027098 |
20 | Hypoglycemic coma (HP:0001325) | 4.02408626 |
21 | Purpura (HP:0000979) | 4.00974212 |
22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99554801 |
23 | Abnormality of glycine metabolism (HP:0010895) | 3.99554801 |
24 | Fat malabsorption (HP:0002630) | 3.89531781 |
25 | Abnormality of complement system (HP:0005339) | 3.89385795 |
26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85975671 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84993486 |
28 | Abnormality of methionine metabolism (HP:0010901) | 3.67290328 |
29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.61561081 |
30 | Hypercholesterolemia (HP:0003124) | 3.59080103 |
31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58948453 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.48507851 |
33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44700490 |
34 | Myocardial infarction (HP:0001658) | 3.36068640 |
35 | Ketoacidosis (HP:0001993) | 3.21654335 |
36 | Prolonged bleeding time (HP:0003010) | 3.11319906 |
37 | Epistaxis (HP:0000421) | 3.10331193 |
38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.08950461 |
39 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.05596964 |
40 | Skin nodule (HP:0200036) | 2.99160964 |
41 | Hepatocellular carcinoma (HP:0001402) | 2.93152194 |
42 | Steatorrhea (HP:0002570) | 2.92220814 |
43 | Hyperbilirubinemia (HP:0002904) | 2.86723780 |
44 | Abnormality of serum amino acid levels (HP:0003112) | 2.76811134 |
45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73241326 |
46 | Hypochromic microcytic anemia (HP:0004840) | 2.63343552 |
47 | Hemorrhage of the eye (HP:0011885) | 2.61221212 |
48 | Delayed CNS myelination (HP:0002188) | 2.59234988 |
49 | Abnormality of purine metabolism (HP:0004352) | 2.57063508 |
50 | Esophageal varix (HP:0002040) | 2.52257927 |
51 | Acanthocytosis (HP:0001927) | 2.51781336 |
52 | Spontaneous abortion (HP:0005268) | 2.51577695 |
53 | Exercise-induced myalgia (HP:0003738) | 2.49974715 |
54 | Spastic diplegia (HP:0001264) | 2.49136350 |
55 | Dicarboxylic aciduria (HP:0003215) | 2.48666371 |
56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48666371 |
57 | Systemic lupus erythematosus (HP:0002725) | 2.48103522 |
58 | Dysostosis multiplex (HP:0000943) | 2.46789327 |
59 | Increased serum ferritin (HP:0003281) | 2.46241593 |
60 | Metabolic acidosis (HP:0001942) | 2.45432487 |
61 | Hypertriglyceridemia (HP:0002155) | 2.43891943 |
62 | Hypoglycemic seizures (HP:0002173) | 2.41661619 |
63 | Mucopolysacchariduria (HP:0008155) | 2.38531945 |
64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38531945 |
65 | Vascular calcification (HP:0004934) | 2.33708221 |
66 | Pancreatitis (HP:0001733) | 2.32588828 |
67 | Abnormality of carpal bone ossification (HP:0006257) | 2.32385489 |
68 | Mitral stenosis (HP:0001718) | 2.31674196 |
69 | Abnormal gallbladder morphology (HP:0012437) | 2.29907114 |
70 | Myositis (HP:0100614) | 2.29327985 |
71 | Protrusio acetabuli (HP:0003179) | 2.27743867 |
72 | Asymmetric septal hypertrophy (HP:0001670) | 2.27728383 |
73 | Cholelithiasis (HP:0001081) | 2.27168930 |
74 | Abnormality of the lumbar spine (HP:0100712) | 2.27164949 |
75 | Abnormal platelet volume (HP:0011876) | 2.25519339 |
76 | Eczematoid dermatitis (HP:0000976) | 2.23475797 |
77 | Flat acetabular roof (HP:0003180) | 2.23224011 |
78 | Orchitis (HP:0100796) | 2.22831223 |
79 | Gout (HP:0001997) | 2.22515866 |
80 | Lethargy (HP:0001254) | 2.20902642 |
81 | Cardiovascular calcification (HP:0011915) | 2.19647544 |
82 | Amyloidosis (HP:0011034) | 2.18740740 |
83 | Retrobulbar optic neuritis (HP:0100654) | 2.17075195 |
84 | Optic neuritis (HP:0100653) | 2.17075195 |
85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16517626 |
86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16517626 |
87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16517626 |
88 | Peritonitis (HP:0002586) | 2.16061030 |
89 | Abnormality of macrophages (HP:0004311) | 2.15093587 |
90 | Impaired platelet aggregation (HP:0003540) | 2.12963842 |
91 | Abnormal platelet function (HP:0011869) | 2.12963842 |
92 | Abnormal cartilage morphology (HP:0002763) | 2.12743103 |
93 | Gingival bleeding (HP:0000225) | 2.11080354 |
94 | Arterial thrombosis (HP:0004420) | 2.10434374 |
95 | Late onset (HP:0003584) | 2.09626875 |
96 | Gastrointestinal infarctions (HP:0005244) | 2.09349227 |
97 | Joint swelling (HP:0001386) | 2.08872897 |
98 | Neonatal onset (HP:0003623) | 2.06904059 |
99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.06178326 |
100 | Glomerulonephritis (HP:0000099) | 2.04769836 |
101 | Abnormality of proline metabolism (HP:0010907) | 2.03119288 |
102 | Hydroxyprolinuria (HP:0003080) | 2.03119288 |
103 | Thrombophlebitis (HP:0004418) | 2.01741884 |
104 | Sensorimotor neuropathy (HP:0007141) | 2.00850408 |
105 | Hyperglycemia (HP:0003074) | 1.99802294 |
106 | Cerebral edema (HP:0002181) | 1.96560088 |
107 | Rickets (HP:0002748) | 1.94814051 |
108 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93797573 |
109 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93797573 |
110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93797573 |
111 | Pigmentary retinal degeneration (HP:0001146) | 1.92945186 |
112 | Irritability (HP:0000737) | 1.92803104 |
113 | Menorrhagia (HP:0000132) | 1.91149568 |
114 | Abnormal gallbladder physiology (HP:0012438) | 1.89896916 |
115 | Cholecystitis (HP:0001082) | 1.89896916 |
116 | Brushfield spots (HP:0001088) | 1.88792775 |
117 | Right ventricular cardiomyopathy (HP:0011663) | 1.88555980 |
118 | Nephritis (HP:0000123) | 1.87148870 |
119 | Abnormality of iron homeostasis (HP:0011031) | 1.86474096 |
120 | Arterial tortuosity (HP:0005116) | 1.86404123 |
121 | Malnutrition (HP:0004395) | 1.86381083 |
122 | Flared iliac wings (HP:0002869) | 1.86092652 |
123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85875547 |
124 | Myoglobinuria (HP:0002913) | 1.85683978 |
125 | Abnormality of the Achilles tendon (HP:0005109) | 1.84487445 |
126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83993613 |
127 | Ulnar deviation of the wrist (HP:0003049) | 1.83264011 |
128 | Renal cortical cysts (HP:0000803) | 1.82888839 |
129 | Hypophosphatemic rickets (HP:0004912) | 1.81814492 |
130 | Vomiting (HP:0002013) | 1.80670147 |
131 | Polycythemia (HP:0001901) | 1.80333703 |
132 | Generalized aminoaciduria (HP:0002909) | 1.78465585 |
133 | Nemaline bodies (HP:0003798) | 1.78240450 |
134 | Abnormality of the gallbladder (HP:0005264) | 1.76669238 |
135 | Poikilocytosis (HP:0004447) | 1.74702295 |
136 | Increased cerebral lipofuscin (HP:0011813) | 1.74286662 |
137 | Stroke (HP:0001297) | 1.73558841 |
138 | Elevated hepatic transaminases (HP:0002910) | 1.72702538 |
139 | Enlarged kidneys (HP:0000105) | 1.72410409 |
140 | Increased mean platelet volume (HP:0011877) | 1.71577564 |
141 | Abnormal tarsal ossification (HP:0008369) | 1.70973824 |
142 | Pulmonary embolism (HP:0002204) | 1.69707477 |
143 | Abnormal delivery (HP:0001787) | 1.69609401 |
144 | Abnormal ossification of hand bones (HP:0005921) | 1.69368221 |
145 | Gangrene (HP:0100758) | 1.66994422 |
146 | Ovoid vertebral bodies (HP:0003300) | 1.66515930 |
147 | Osteomalacia (HP:0002749) | 1.65658766 |
148 | Recurrent abscess formation (HP:0002722) | 1.65508554 |
149 | Vacuolated lymphocytes (HP:0001922) | 1.65338609 |
150 | Distal arthrogryposis (HP:0005684) | 1.65145229 |
151 | Vascular tortuosity (HP:0004948) | 1.63671668 |
152 | Broad palm (HP:0001169) | 1.63504377 |
153 | Cerebral aneurysm (HP:0004944) | 1.63058954 |
154 | Small epiphyses (HP:0010585) | 1.62562517 |
155 | Asymmetry of the thorax (HP:0001555) | 1.61575791 |
156 | Cupped ribs (HP:0000887) | 1.60506074 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.31087832 |
2 | SIK1 | 4.88618107 |
3 | FGFR4 | 4.00446883 |
4 | TRIB3 | 3.72609185 |
5 | ERN1 | 3.68005646 |
6 | PKN2 | 2.92426839 |
7 | CAMK1D | 2.51160055 |
8 | PRPF4B | 2.40486883 |
9 | INSRR | 2.33949928 |
10 | LATS1 | 2.00802689 |
11 | MST1R | 1.92184685 |
12 | TAOK3 | 1.88160150 |
13 | RIPK4 | 1.86844438 |
14 | CDK12 | 1.83934872 |
15 | RIPK1 | 1.75448287 |
16 | PIK3CG | 1.73292646 |
17 | CAMK1G | 1.64652896 |
18 | FLT3 | 1.64561213 |
19 | PTK6 | 1.62867146 |
20 | FGFR3 | 1.61989737 |
21 | FGFR2 | 1.58141796 |
22 | TYK2 | 1.56234915 |
23 | JAK1 | 1.52765793 |
24 | MAP3K10 | 1.51785385 |
25 | ERBB4 | 1.50569707 |
26 | MAPK11 | 1.49259392 |
27 | FRK | 1.44897860 |
28 | EPHB1 | 1.43423377 |
29 | KIT | 1.40531070 |
30 | MAP3K6 | 1.38996865 |
31 | CDK6 | 1.35314231 |
32 | NEK9 | 1.31374120 |
33 | DDR2 | 1.28792592 |
34 | MAP3K7 | 1.26947257 |
35 | MATK | 1.26257062 |
36 | MUSK | 1.23221692 |
37 | PRKAA2 | 1.21696846 |
38 | JAK2 | 1.20734620 |
39 | EPHA3 | 1.19855063 |
40 | BLK | 1.08730633 |
41 | TGFBR2 | 1.06308490 |
42 | MAP2K4 | 1.05614917 |
43 | KDR | 1.05029863 |
44 | FGR | 1.03742710 |
45 | MAP3K2 | 0.99444855 |
46 | SMG1 | 0.99182833 |
47 | MAP2K3 | 0.96946907 |
48 | MARK2 | 0.96224553 |
49 | MAP3K1 | 0.95470634 |
50 | SYK | 0.94648688 |
51 | TBK1 | 0.92657329 |
52 | PDGFRA | 0.91275161 |
53 | IRAK4 | 0.89382727 |
54 | AKT3 | 0.86594855 |
55 | TIE1 | 0.84119226 |
56 | PIK3CA | 0.84073241 |
57 | BTK | 0.83748354 |
58 | ERBB2 | 0.80527953 |
59 | FES | 0.80215259 |
60 | WNK1 | 0.80188872 |
61 | CSK | 0.79834286 |
62 | MAP3K3 | 0.78927861 |
63 | DAPK2 | 0.78679277 |
64 | MTOR | 0.78156259 |
65 | RET | 0.77974455 |
66 | MET | 0.76018732 |
67 | ITK | 0.75874935 |
68 | CDC42BPA | 0.74090524 |
69 | DYRK1B | 0.73513009 |
70 | PDK4 | 0.73065619 |
71 | PDK3 | 0.73065619 |
72 | STK24 | 0.71287591 |
73 | MAPK12 | 0.70901785 |
74 | JAK3 | 0.70620400 |
75 | TAOK2 | 0.70199191 |
76 | HCK | 0.69121223 |
77 | MAP4K1 | 0.68735254 |
78 | IKBKE | 0.68569485 |
79 | ZAP70 | 0.68461824 |
80 | MAP2K1 | 0.67435997 |
81 | SCYL2 | 0.67315787 |
82 | PTK2 | 0.66830944 |
83 | GRK6 | 0.66760473 |
84 | KSR2 | 0.66446725 |
85 | MOS | 0.65907569 |
86 | LCK | 0.65881885 |
87 | MAP3K14 | 0.65215424 |
88 | PRKAA1 | 0.64592407 |
89 | CDK4 | 0.63913243 |
90 | TTN | 0.62210207 |
91 | SGK2 | 0.61613903 |
92 | TEC | 0.61517671 |
93 | MAPK15 | 0.61454700 |
94 | ABL2 | 0.60943987 |
95 | IRAK1 | 0.60231261 |
96 | GSK3A | 0.59708294 |
97 | FGFR1 | 0.58138988 |
98 | STK10 | 0.57835694 |
99 | LYN | 0.57327117 |
100 | IGF1R | 0.55643525 |
101 | PDPK1 | 0.55494001 |
102 | SGK3 | 0.55376407 |
103 | MAP2K6 | 0.54765262 |
104 | HIPK2 | 0.54722785 |
105 | LRRK2 | 0.53097163 |
106 | FER | 0.51749710 |
107 | MAPK4 | 0.51431441 |
108 | YES1 | 0.51188380 |
109 | PRKACG | 0.48887897 |
110 | PDK1 | 0.47840398 |
111 | NLK | 0.47787058 |
112 | PDGFRB | 0.47080179 |
113 | CDK9 | 0.46989766 |
114 | LMTK2 | 0.46655963 |
115 | PRKCH | 0.45751896 |
116 | PRKCQ | 0.45664708 |
117 | CSF1R | 0.45309393 |
118 | IRAK3 | 0.44802235 |
119 | PRKCZ | 0.42945867 |
120 | BMX | 0.41093498 |
121 | ICK | 0.39978996 |
122 | MAPK7 | 0.38501612 |
123 | CHUK | 0.37253897 |
124 | STK3 | 0.37153331 |
125 | OBSCN | 0.35436549 |
126 | TXK | 0.35408775 |
127 | MAP3K5 | 0.35325415 |
128 | EGFR | 0.33415527 |
129 | PRKD1 | 0.32454146 |
130 | MYLK | 0.31278779 |
131 | EPHA2 | 0.30545492 |
132 | EEF2K | 0.30254066 |
133 | MELK | 0.29837337 |
134 | TRPM7 | 0.29618013 |
135 | STK38L | 0.28786869 |
136 | PAK2 | 0.27770804 |
137 | MAP3K13 | 0.27503035 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.28001917 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.69177112 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13109759 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09989602 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.94991523 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.79304987 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.64262500 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.60386346 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59874193 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57847094 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56983821 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55941428 |
13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.41659351 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40299252 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.30619418 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18307260 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.04912332 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01125012 |
19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00668024 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91083894 |
21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.84672966 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84016905 |
23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83842740 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80435659 |
25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77029046 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.71242189 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69889656 |
28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.69587637 |
29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61570782 |
30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56285019 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54661864 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54305410 |
33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.50927480 |
34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50517179 |
35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49306005 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47212446 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42276939 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40899370 |
39 | Bile secretion_Homo sapiens_hsa04976 | 1.38097905 |
40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.30287875 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29596907 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.28719889 |
43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27249255 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24549331 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.23773617 |
46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.23523616 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19446154 |
48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.13578693 |
49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11996815 |
50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09585587 |
51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06876874 |
52 | Lysosome_Homo sapiens_hsa04142 | 1.04477016 |
53 | Platelet activation_Homo sapiens_hsa04611 | 1.02906733 |
54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99679000 |
55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99610816 |
56 | Lysine degradation_Homo sapiens_hsa00310 | 0.98345490 |
57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92896480 |
58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91241731 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90183370 |
60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.87627867 |
61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86898855 |
62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86688081 |
63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79238986 |
64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78495127 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76734435 |
66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76515201 |
67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75157466 |
68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73084782 |
69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71693488 |
70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70858500 |
71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70592966 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65720227 |
73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65612003 |
74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65175814 |
75 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64345187 |
76 | Malaria_Homo sapiens_hsa05144 | 0.62780028 |
77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58274161 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.58068042 |
79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57954919 |
80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54668111 |
81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54043233 |
82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53592548 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52428943 |
84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52395269 |
85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52376694 |
86 | Tuberculosis_Homo sapiens_hsa05152 | 0.50731026 |
87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49794403 |
88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49313078 |
89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46818650 |
90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45517834 |
91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44219181 |
92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42683791 |
93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38745023 |
94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38371728 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37129666 |
96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34176809 |
97 | Focal adhesion_Homo sapiens_hsa04510 | 0.32431279 |
98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32249317 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.32208795 |
100 | Influenza A_Homo sapiens_hsa05164 | 0.32096980 |
101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32077970 |
102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31748113 |
103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.30796593 |
104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30235714 |
105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29865545 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24591282 |
107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22442563 |
108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21944556 |
109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18005290 |
110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17983357 |
111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10919582 |
112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06539464 |
113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.05046973 |
114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01481157 |
115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.00863107 |
116 | Bladder cancer_Homo sapiens_hsa05219 | -0.1673465 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1636849 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.1594804 |
119 | Adherens junction_Homo sapiens_hsa04520 | -0.1436304 |
120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.1369804 |
121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1318416 |
122 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1195228 |
123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1019154 |
124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0985187 |
125 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0933039 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0845835 |
127 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0682334 |
128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0676847 |
129 | Hepatitis C_Homo sapiens_hsa05160 | -0.0362415 |
130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0289699 |
131 | Amoebiasis_Homo sapiens_hsa05146 | -0.0085416 |